It was reported that on (b)(6) 2023, a 25mm amplatzer amulet left atrial appendage (laa) occluder was implanted successfully on the pulmonary ridge utilizing a 14f amplatzer torqvue delivery system.After release, the device was nudged by the delivery cable further into the appendage in a technique error by the physician.The patient presented with a friable laa with prominent transverse sinus.After the implantation, the patient was put on dual antiplatelet therapy as an anti-thrombotic regimen.On 26 november 2023, the patient developed dyspnea and angina.Further observation reveal pericardial effusion leading to cardiac tamponade.The patient was given heparin and pericardiocentesis was performed, removing 1400cc of fluid.The patient is reported to be stable.Anti-thrombotic regimen was not adjusted.The effusion was located behind the appendage on underside, and it was a slow leak the physician thought the pericardial effusion was caused by the migration of the device further into the laa by the delivery cable as the device was being released during the implantation procedure.The patient is reported to be stable.
|
An event of dyspnea and angina and pericardial effusion leading to cardiac tamponade was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported incident may be due to the error that occurred during the procedure.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|